- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02096783
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
Randomized-Controlled, Pilot Study of the Effects of a Brief, Scripted Sexual Health Intervention on Sexual Function for Women With Gynecologic Cancer
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
PRIMARY OBJECTIVES:
I. To evaluate the feasibility of patient recruitment, including time required to consent, enroll and retain the necessary number of participants.
II. To determine the distribution of candidate primary patient-reported outcome measures, including time to resumption of sexual activity, global satisfaction with sex life, sexual function and anxiety in this particular population.
III. To establish the prevalence of patient recall of the intervention to determine the most effective time at which to deliver the intervention.
OUTLINE: Patients are randomized to 1 of 4 treatment arms.
ARM I: Patients receive standard counseling at both the pre-operative and 2-4 week post-operative visit.
ARM II: Patients receive standard counseling at the pre-operative visit and the scripted sexual health intervention at the 2-4 week post-operative visit.
ARM III: Patients receive standard counseling and the scripted sexual health intervention at the pre-operative visit and standard counseling at the 2-4 week post-operative visit.
ARM IV: Patients receive standard counseling and the scripted sexual health intervention at both the pre-operative and 2-4 week post-operative visit.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Wisconsin
-
Madison, Wisconsin, Forenede Stater, 53792
- University of Wisconsin, Madison
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients with a new suspected or confirmed gynecologic malignancies
- Patients plan to have primary surgery at either the University of Chicago Hospital or the University of Wisconsin Hospital
- Patients must be English speaking
Exclusion Criteria:
- Previous treatment of any cancer excluding skin cancer
- Patients with a suspected benign gynecologic process
- Patients who are prisoners or incarcerated
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Arm I (standard counseling)
Patients receive standard counseling at both the pre-operative and 2-4 week post-operative visit.
|
Hjælpestudier
Given standard counseling
Andre navne:
|
|
Eksperimentel: Arm II (standard counseling, scripted intervention)
Patients receive standard counseling at the pre-operative visit and the scripted sexual health intervention at the 2-4 week post-operative visit.
|
Hjælpestudier
Given standard counseling
Andre navne:
Given scripted intervention
|
|
Eksperimentel: Arm III (standard counseling, scripted intervention)
Patients receive standard counseling and the scripted sexual health intervention at the pre-operative visit and standard counseling at the 2-4 week post-operative visit.
|
Hjælpestudier
Given standard counseling
Andre navne:
Given scripted intervention
|
|
Eksperimentel: Arm IV (standard counseling, scripted intervention)
Patients receive standard counseling and the scripted sexual health intervention at both the pre-operative and 2-4 week post-operative visit.
|
Hjælpestudier
Given standard counseling
Andre navne:
Given scripted intervention
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility of patient recruitment
Tidsramme: Up to 9 months
|
To inform possible issues in recruitment for a large-scale randomized controlled trial, the ratio of enrolled subjects to total eligible potential subjects as well as the time necessary to recruit those subjects will be tracked.
|
Up to 9 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Resumption of sexual activity after cancer surgery
Tidsramme: Up to 9 months
|
Resumption of sexual activity after cancer surgery will be measured using items adapted from a previous national, multi-site study of sexual outcomes following an acute myocardial infarction.
|
Up to 9 months
|
|
Retention
Tidsramme: Up to 9 months
|
The percentage of subjects completing the final assessment from the total number of subjects enrolled will be calculated.
|
Up to 9 months
|
|
Satisfaction with sex life independent of specific sexual function measured by Patient Reported Outcomes Measurement Information System (PROMIS) Global Satisfaction with Sex Life questionnaire
Tidsramme: Up to 9 months
|
Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms.
|
Up to 9 months
|
|
PROMIS Sexual Function Profile
Tidsramme: Up to 9 months
|
Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms.
|
Up to 9 months
|
|
Recall of intervention
Tidsramme: Up to 9 months
|
Subjects will be queried to learn whether they recall receiving physician counseling about sexual health outcomes after surgery with follow up questions regarding whether or not the patient has spoken with other healthcare providers about sexual concerns.
|
Up to 9 months
|
|
Patient-reported anxiety measured by PROMIS Anxiety 4a short form
Tidsramme: Up to 6 months
|
Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms.
|
Up to 6 months
|
|
Rate of referral acceptance
Tidsramme: Up to 9 months
|
The rate of acceptance of sexual health clinic referrals as well as rates of utilization of these referrals will be tracked using medical record abstraction.
|
Up to 9 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: David Kushner, University of Wisconsin, Madison
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Psykiske lidelser
- Neoplasmer efter histologisk type
- Neoplasmer
- Urogenitale neoplasmer
- Neoplasmer efter sted
- Karcinom
- Neoplasmer, kirtel og epitel
- Uterine neoplasmer
- Genitale neoplasmer, kvindelige
- Livmodersygdomme
- Sygdomme i det endokrine system
- Ovariesygdomme
- Adnexale sygdomme
- Gonadale lidelser
- Neoplasmer i endokrine kirtler
- Neoplasmer, kimceller og embryonale
- Graviditetskomplikationer
- Vaginale sygdomme
- Vulva sygdomme
- Ovariale neoplasmer
- Graviditetskomplikationer, neoplastiske
- Angstlidelser
- Endometriale neoplasmer
- Karcinom, ovarieepitel
- Vulva neoplasmer
- Trofoblastiske neoplasmer
- Vaginale neoplasmer
Andre undersøgelses-id-numre
- UW13080 (Anden identifikator: University of Wisconsin Carbone Cancer Center)
- P30CA014520 (U.S. NIH-bevilling/kontrakt)
- A532820 (Anden identifikator: UW Madison)
- SMPH/OBSTET & GYNECOL/OBSTET (Anden identifikator: UW Madison)
- NCI-2014-00471 (Registry Identifier: NCI Trial ID)
- 2014-0122 (Anden identifikator: Institutional Review Board)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Livmoderhalskræft
-
Assiut UniversityIkke rekrutterer endnuCervikal Degenerativ Disc Sygdom | Anterior Cervical Discectomy and Fusion (ACDF) | Cervical Cage med Skrue
-
Xin Jiang, MDUkendt
-
Kasr El Aini HospitalIkke rekrutterer endnuAnterior Cervical Discectomy and Fusion (ACDF)
-
University of ArkansasAfsluttetAnterior Cervical Discectomy and Fusion (ACDF)Forenede Stater
-
Gangnam Severance HospitalAfsluttetAnterior Cervical Discectomy and Fusion (ACDF) kirurgiKorea, Republikken
-
Hospital del Trabajador de SantiagoRekrutteringSkulderkirurgi | Brachial Plexus blokade | Overfladisk Cervical Plexus BlockChile
-
Cleveland Clinic Akron GeneralAfsluttetSmerte | Overfladisk Cervical Plexus BlockForenede Stater
-
Tanta UniversityRekrutteringUltralyd | Overfladisk Cervical Plexus Block | Clavipectoral fascial planblok | Interscalen brachial blok | Clavicle -operationerEgypten
-
Hamilton Health Sciences CorporationMcMaster UniversityRekruttering
-
AxioMed Spine CorporationUkendtSymptomatisk Cervical Degenerative Disc Disease (DDD) Fra C3-C7Tyskland, Schweiz
Kliniske forsøg med spørgeskemaadministration
-
Academisch Medisch Centrum - Universiteit van Amsterdam...AfsluttetAnalgesi | Akutte smerter på grund af traumerHolland
-
Universitas Sumatera UtaraAfsluttetTilstand / Fokus: Postoperativ kognitiv dysfunktion (POCD) efter rygsøjleoperationIndonesien
-
Camilo Jose Cela UniversityAfsluttet
-
VivatechAfsluttet
-
Laekna LimitedRekrutteringOvervægtige og fede frivilligeKina
-
University of CalgaryIkke rekrutterer endnuKoronararteriesygdom | Hjertefejl | Diabetes mellitus | Kroniske lungesygdomme | Nyre sygdomCanada
-
Catholic University of the Sacred HeartAfsluttetLivskvalitet | Kirurgisk sår | Biopsi sår | Heling af kirurgiske sårItalien
-
MWolztUkendt
-
J2H BiotechAfsluttetIkke-alkoholisk SteatohepatitisSydkorea
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulUkendtAldring | Interaktion Drug Food | Primær hypothyroidismeBrasilien